SINGLE-LUNG TRANSPLANTATION IN EMPHYSEMA

F. J. Veith, S. K. Koerner, L. A. Attai, P. Bardfeld, S. J. Boley, A. Bloomberg, M. Everhard, J. Anderson, B. Pollara, R. Steckler, H. Nagashima, S. Siegelman, P. Lalezari, M. L. Gliedman

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

A patient with severe bilateral emphysema has survived more than 31/2 months after receiving a single-lung allograft. At least seven presumed episodes of rejection were identified and reversed by massive pulsed intravenous doses of methyl prednisolone. When allograft rejection was controlled, no serious or progressive ventilation-perfusion imbalances occurred and the allograft provided the majority of effective ventilation and pulmonary blood-flow, with consequent improvement in the patient's respiratory status.

Original languageEnglish (US)
Pages (from-to)1138-1139
Number of pages2
JournalThe Lancet
Volume299
Issue number7761
DOIs
StatePublished - May 27 1972

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'SINGLE-LUNG TRANSPLANTATION IN EMPHYSEMA'. Together they form a unique fingerprint.

  • Cite this

    Veith, F. J., Koerner, S. K., Attai, L. A., Bardfeld, P., Boley, S. J., Bloomberg, A., Everhard, M., Anderson, J., Pollara, B., Steckler, R., Nagashima, H., Siegelman, S., Lalezari, P., & Gliedman, M. L. (1972). SINGLE-LUNG TRANSPLANTATION IN EMPHYSEMA. The Lancet, 299(7761), 1138-1139. https://doi.org/10.1016/S0140-6736(72)91371-2